<div id="readability-page-1"><div>The sharp selloff in ICICI Prudential Life Insurance following Prudential plc’s decision to acquire a controlling stake in Bharti AXA Life Insurance has reignited investor concerns around the insurer’s growth trajectory, with fears of a large block-deal overhang adding to worries over bancassurance-led growth slowdown and ongoing valuation de-rating, market experts told Moneycontrol.The immediate trigger for the May 18 selloff was Prudential Plc’s proposed acquisition of a 75% stake in Bharti Life Insurance, which would require the UK insurer to cut its roughly 22% holding in ICICI Prudential Life to below 10% under Indian insurance regulations. The prospect of a nearly 12% stake sale — estimated at around Rs 9,200 crore — has heightened concerns over sustained selling pressure and further valuation compression at a time when the insurer is already grappling with relatively weaker growth versus industry peers.While most brokerages do not see any immediate operational impact, the move has amplified an existing market debate: whether ICICI Prudential Life’s transition toward slower but higher-quality growth structurally caps its valuation multiples.Bernstein struck the most cautious tone, arguing Prudential may effectively be “throwing in the towel” on meaningful value creation through its minority holding in ICICI Prudential Life and instead pivoting toward a controlling position in Bharti Life where it can drive strategy and distribution directly. The brokerage noted that the stock “is cheap and will likely get cheaper,” questioning who would absorb the large stake sale without demanding a discount.Axis Capital also flagged concerns around market-share losses, weaker persistency trends and elevated expense ratios, while maintaining an “Add” rating with a target price of Rs 625. The brokerage said growth remains modest despite healthy profitability metrics and stronger traction in protection products.In contrast, Morgan Stanley maintained an “Overweight” rating with a Rs 670 target price, arguing the Prudential transaction does not alter ICICI Prudential Life’s core operating fundamentals. Nomura retained its “Buy” rating with a Rs 680 target price, pointing out that the stock had already materially underperformed both the broader market and peers before the latest selloff.A central issue weighing on investor sentiment is the insurer’s post-2018 shift away from aggressive bancassurance-led growth after Sandeep Bakhshi took over as CEO of ICICI Bank. Under tighter governance and stricter controls on mis-selling, ICICI Prudential’s dependence on the ICICI Bank channel sharply reduced, bringing down banca contribution from roughly 70-75% historically to about 26-30% of annual premium equivalent.While the transition improved product quality, diversified distribution and strengthened margins, analysts say it also capped aggressive volume growth, pushing investors to reassess the company more as a steady profitability compounder rather than a high-growth insurance franchise.Recent earnings reinforced that perception. Management refrained from giving aggressive growth guidance for FY27 and instead emphasised protection-led growth, margin expansion and cost efficiency amid a volatile macro backdrop. Annual premium equivalent growth remained modest, though value of new business margins improved sharply due to a better product mix.The result is a stock that now trades at one of the lowest valuation multiples among large listed insurers. ICICI Prudential Life trades at around 1.3-1.5 times FY27 embedded value, below peers such as HDFC Life Insurance and SBI Life Insurance.For bulls, that discount alongside strong solvency, improving protection mix and resilient profitability offers a potential floor for valuations. For bears, the Prudential stake-sale overhang, slower growth profile and muted distribution momentum raise questions about whether a meaningful rerating is possible in the near term.</div></div>

ICICI Prudential Life Insurance's stock has faced a selloff following Prudential plc's acquisition of a controlling stake in Bharti AXA Life Insurance, raising concerns about growth and potential valuation compression. The sale of a nearly 12% stake in ICICI Prudential is feared to increase selling pressure. While some brokerages maintain positive ratings, others express caution over market-share losses and slower growth. The insurer's shift from aggressive bancassurance growth has led to a reassessment of its valuation, trading at lower multiples compared to peers.

Money Control

Prudential USD

Prudential

Prudential plc

Morgan Stanley

Nomura Holdings, Inc.

Nomura

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

Macquarie Energy Transition ETF

Prudential’s Bharti Life Bet Triggers Fresh Overhang Fears for ICICI Pru Life